ESTIMATED non-binding
fees for IVF/ICSI are for information purposes only and
are subject to change without notice. A $3,000.00 prepayment
is required before you start the program. This will create
a credit balance on your billing statement, and charges
will be applied as services are rendered. Any portion
remaining after completion of this program will be promptly refunded.
This prepayment does not cover
the cost of medications.
Please contact Mary
Lea at (601) 984-5310 regarding your prepayment and possible
filing of your insurance for reimbursement.
We emphasize that these
estimates are based on an average cycle. Your
cycle could be longer and therefore more expensive. Also,
if your physician determines that intracytoplasmic
sperm injection (ICSI) is needed, an additional charge
of $1,250.00 is incurred when we complete this extra
therapy.
Medications* (e.g.
Follistim, Pergonal, Humegon, Fertinex and Lupron)
are charged separately by your pharmacist when your
prescription is filled. Thus, this estimated cost
may vary by your pharmacist or treatment requirements.
Oocyte donation is a treatment available for couples
who cannot become pregnant during standard in vitro
fertilization (IVF) using the wife’s eggs. Examples
include:
- patients
with ovarian failure (early menopause),
- repeated
IVF failures,
- potentially
transmissible maternal genetic disorders, or
- advanced
maternal age
During the egg
donation procedure, eggs obtained from a donor are fertilized
using the recipient's husband's sperm and the
resulting embryos are placed into the recipient's
uterus. Currently, approximately 40% of couples who
complete a single course of this therapy will establish
a pregnancy. This pregnancy rate represents one of
the highest pregnancy rates that results from assisted
reproductive technologies.
Egg donors
in this program are anonymous, will be compensated
for their inconvenience, and voluntarily agree to
participate. There is no contact between the
donor and the recipient. The identities of
each party are held in strictest confidence. All
potential donors undergo a thorough screen consisting
of:
- a medical
and genetic history,
- a physical
examination,
- psychological
screening, and
- testing
for sexually transmitted diseases including HIV
- Additionally,
egg donors will be subject to random screening
for illicit drug use
Non-identifying
demographic information that is available to assist in
the selection of a prospective donor include:
- height,
- weight,
- eye color,
- hair
color,
- education,
- occupation,
- blood
type, and
- Rh factor
- Anonymous
donors will be > 21 and < 34 years of age when
donating
Recipients for
egg donation undergo a screening process similar to that
for egg donors. This consists of a history and physical
examination, assessment of the uterine cavity (hysterosalpingogram
or ultrasound), psychological screening for the recipient
and partner and testing for sexually transmitted diseases
including HIV. Currently, our cut-off for recipients
is 50 years of age.
Treatment Guidelines
Preparation
for egg donation requires treatment with medications
designed to stimulate the development of as many eggs as
possible within the ovaries. This widely used treatment
protocol is identical to that used for patients undergoing
IVF. This treatment can be divided into the following
steps:
Ovarian
Suppression The initial step of the stimulation
process involves administration of a medication, called
Lupron that produces a temporary menopausal state. This
medication is typically started on day 21 of your menstrual
cycle and continued for approximately two weeks prior
to stimulation. We use this medication in an
attempt to prevent a premature release of eggs from
the ovary and to synchronize egg development. Many
patients experience symptoms of menopause such as hot
flashes while taking this medication.
Ovarian
Stimulation Following ovarian suppression with
Lupron, stimulation with gonadotropins (Fertinex) is
begun. This medication is given in the form of
a subcutaneous (under the skin) injection to stimulate
the development of eggs within the ovary. Most
patients are able to administer these injections themselves. During
the stimulation phase (typically 10 to 12 days), the
egg donor will come to our office for ultrasound monitoring
of follicular (egg) development and blood testing for
estrogen levels. When the follicles have achieved
maturity, an injection of human chorionic gonadotropin
(hCG) is given to trigger the final phase of maturation.
Egg
Retrieval The final phase of egg donation involves
the extraction of eggs from the ovary. In this
office-based procedure, the egg donor is given sedation
with intravenous medications to make the procedure as
comfortable as possible. Using vaginal ultrasound,
a needle is directed through the vaginal wall into the
ovary and the eggs are removed. The eggs are taken
to the IVF laboratory where they are examined and fertilized
with the recipient's husband's sperm. Most
egg donors are able to return to work the day after the
procedure. It is essential to take precautions
to avoid pregnancy during the remainder of the cycle. A
follow-up visit will be scheduled approximately one to
two weeks after the egg retrieval.
Egg Donor Expectations: We
recognize that your decision to participate in our program
as an egg donor requires a great deal of work and inconvenience
on your part. Accordingly, egg donors are reimbursed
for their special efforts and inconvenience according to the
following schedule. These reimbursements are subject
to taxation and will be reported to the IRS as miscellaneous
income on form 1099-M.
Schedule for reimbursements:
| Lupron injections
for ovarian suppression only |
50.00 |
| Injections
for ovarian stimulation with ultrasounds and blood
testing |
100.00 |
| Egg retrieval |
1,750.00 |
| Follow-up
visit |
100.00 |
| Total: |
$
2,000.00 |
It is essential that
you understand that failure to abide by the treatment protocol
and maintain compliance with medications and the treatment
schedule may result in cancellation of the treatment protocol. You
must also recognize that it is important not to engage in
any high-risk behavior which might result in an increased
risk for sexually transmitted diseases.
If you have any questions
after reading this information or need help completing your
questionnaire, please do not hesitate to call. We look
forward to talking more with you about this exciting treatment
in the near future.
|